BioSpace News Archive

Scientists have shown how measles causes long-term damage to the immune system, leaving people vulnerable to other infections.

Further German cooperation with the Paracelsus Clinic in Zwickau and first NanoTherm treatment center outside of Germany opened at the Independent Public Clinical Hospital No. 4 (SPKS4) in Lublin, Poland

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced it will present new data on the safety and efficacy of the company’s lead investigational candidate, AR101 (trade name Palforzia™), at the American College of Asthma, Allergy and Immunology (ACAAI) Annual Scientific Meeting, taking place November 7-11, 2019, in Houston

Rising Medical Solutions executive, Rachel Fikes, has assumed a new, elevated position with the company as it looks to create further value for its two primary constituencies – its customers and its employee shareholders.

MYOS RENS Technology Inc., an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, will announce financial results for the third quarter of 2019 on Friday, November 8 at 10 AM

Zyla Life Sciences, a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, announced that its third quarter 2019 financial results will be released on Thursday, November 14, 2019.

NanoString Technologies, Inc., a leading provider of life science tools for translational research and molecular diagnostic products, announced the appointment of Don Kania, Ph.D.

Continued clinical progress with four ongoing phase 3 pivotal trials creating the potential for substantial market expansion over the next five years

Syneos Health, a leading biopharmaceutical solutions organization combining a Contract Research Organization and a Contract Commercial Organization, reported financial results for the three and nine months ended September 30, 2019.

ChromaDex Corp. announced its Tru Niagen® product was recognized as “MoneyBack Members’ Most Favourite Brand” at the Health, Wellness & Beauty Awards 2019 held in Hong Kong on October 24.